Marksans Pharma Ltd. — Investor Relations & Filings
Marksans Pharma Ltd. specializes in the research, development, and large-scale manufacturing of generic formulations. The company’s therapeutic focus spans pain management, cardiovascular health, central nervous system disorders, anti-diabetics, and gastrointestinal treatments. Its product portfolio includes diverse delivery systems such as solid orals, soft gelatin capsules, and liquid formulations, serving both the over-the-counter and prescription markets. The organization operates advanced manufacturing facilities compliant with international regulatory standards, facilitating a robust supply chain across major global markets including North America, Europe, and Australia. By integrating comprehensive research and development with efficient production processes, the company provides a broad range of high-quality, cost-effective medicinal products to a global patient base.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-19 | English | |
| The Company has scheduled a conference call for analysts and investors on Wednesday, May 27, 2026 at 04:30 PM (IST) to discuss the Audited Financial Results (Standalone and Consolidated) .... | 2026-05-19 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-05-19 | English | |
| Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated .... | 2026-05-12 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-09 | English | |
| Press Release | 2026-04-01 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ENANTA PHARMACEUTICALS INC
Biotechnology company developing small molecule drugs for v…
|
ENTA | US | Manufacturing |
|
Enervit
Develops sports nutrition, functional foods, and wellness s…
|
ENV | IT | Manufacturing |
|
enGene Holdings Inc.
Clinical-stage biotech developing non-viral gene therapies …
|
ENGN | CA | Manufacturing |
|
Enliven Therapeutics, Inc.
Clinical-stage biopharma developing kinase inhibitors for p…
|
ELVN | US | Manufacturing |
|
Enlivex Therapeutics Ltd.
A clinical-stage macrophage reprogramming immunotherapy com…
|
ENLV | IL | Manufacturing |
|
Enlivex Therapeutics Ltd.
Develops macrophage reprogramming immunotherapy for inflamm…
|
ENLV | US | Manufacturing |
|
Enorama Pharma AB
Develops and manufactures medicated chewing gums and tobacc…
|
ERMA | SE | Manufacturing |
|
Ensol Biosciences Inc.
AI-driven biopharma developing peptide drugs for unmet medi…
|
140610 | KR | Manufacturing |
|
Entera Bio Ltd.
A clinical-stage company developing oral peptide and protei…
|
ENTX | IL | Manufacturing |
|
Entero Therapeutics, Inc.
Clinical-stage biopharma developing oral therapies for gast…
|
ENTO | US | Manufacturing |
Marksans Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62142/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62142 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62142 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62142 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62142}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Marksans Pharma Ltd. (id: 62142)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.